K. Matsuoka, M. Watanabe, T. Ohmori, Koichi Nakajima, T. Ishida, Y. Ishiguro, K. Kanke, K. Kobayashi, Fumihito Hirai, Kenji Watanabe, H. Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, T. Kajioka, T. Hibi
{"title":"AJM300(甲基胡萝卜素),α4整合素的口服拮抗剂,作为中度活动性溃疡性结肠炎患者的诱导治疗:一项多中心、随机、双盲、安慰剂对照的3期研究","authors":"K. Matsuoka, M. Watanabe, T. Ohmori, Koichi Nakajima, T. Ishida, Y. Ishiguro, K. Kanke, K. Kobayashi, Fumihito Hirai, Kenji Watanabe, H. Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, T. Kajioka, T. Hibi","doi":"10.1016/s2468-1253(22)00022-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.\",\"authors\":\"K. Matsuoka, M. Watanabe, T. Ohmori, Koichi Nakajima, T. Ishida, Y. Ishiguro, K. Kanke, K. Kobayashi, Fumihito Hirai, Kenji Watanabe, H. Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, T. Kajioka, T. Hibi\",\"doi\":\"10.1016/s2468-1253(22)00022-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":114609,\"journal\":{\"name\":\"The lancet. Gastroenterology & hepatology\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The lancet. Gastroenterology & hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2468-1253(22)00022-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The lancet. Gastroenterology & hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2468-1253(22)00022-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.